請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/16143
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 郭彥彬 | |
dc.contributor.author | Yi-Ting Deng | en |
dc.contributor.author | 鄧伊婷 | zh_TW |
dc.date.accessioned | 2021-06-07T18:02:40Z | - |
dc.date.copyright | 2012-09-19 | |
dc.date.issued | 2012 | |
dc.date.submitted | 2012-08-01 | |
dc.identifier.citation | A.M. Gressner, R. Weiskirchen, K. Breitkopf, Dooley S (2002). Roles of TGF-beta in hepatic fibrosis Front Biosci 7(1):793-807.
Aggarwal BB, Sundaram C, Malani N, Ichikawa H (2007). Curcumin: the Indian solid gold. Adv Exp Med Biol 595(1):1-75. Albright CD, Salganik RI, Craciunescu CN, Mar MH, Zeisel SH (2003). Mitochondrial and microsomal derived reactive oxygen species mediate apoptosis induced by transforming growth factor-beta1 in immortalized rat hepatocytes. J Cell Biochem 89(254-261. Allen JT, Knight RA, Bloor CA, Spiteri MA (1999). Enhanced insulin-like growth factor binding protein-related protein 2 (Connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Cell Mol Biol 21(6):693-700. Amara N, Goven D, Prost F, Muloway R, Crestani B, Boczkowski J (2010). NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts. Thorax 65(8):733-738. Ambalavanan N, Nicola T, Hagood J, Bulger A, Serra R, Murphy-Ullrich J et al. (2008). Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung. Am J Physiol Lung Cell Mol Physiol 295(1):L86-95. Angadi PV, Kale AD, Hallikerimath S (2011). Evaluation of myofibroblasts in oral submucous fibrosis: correlation with disease severity. J Oral Pathol Med 40(3):208-213. Babic AM, Chen CC, Lau LF (1999). Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 19(4):2958-2966. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL (2002). p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 115(Pt 15):3193-3206. Barcellos-Hoff MH, Dix TA (1996). Redox-mediated activation of latent transforming growth factor-beta 1. Molecular endocrinology (Baltimore, Md) 10(9):1077-1083. Barnes JL, Gorin Y (2011). Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int 79(9):944-956. Bedard K, Krause KH (2007). The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological reviews 87(1):245-313. Bellocq A, Azoulay E, Marullo S, Flahault A, Fouqueray B, Philippe C et al. (1999). Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol 21(1):128-136. Blom IE, van Dijk AJ, de Weger RA, Tilanus MG, Goldschmeding R (2001). Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms. Mol Pathol 54(3):192-196. Bonniaud P, Margetts PJ, Kolb M, Schroeder JA, Kapoun AM, Damm D et al. (2005). Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med 171(8):889-898. Bradham DM, Igarashi A, Potter RL, Grotendorst GR (1991). Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114(6):1285-1294. Brigstock DR, Steffen CL, Kim GY, Vegunta RK, Diehl JR, Harding PA (1997a). Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. The Journal of biological chemistry 272(32):20275-20282. Brigstock DR, Steffen CL, Kim GY, Vegunta RK, Diehl JR, Harding PA (1997b). Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J Biol Chem 272(32):20275-20282. Burgess JK, Q.Ge. (2006). connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix. Am J Physio Lung Cell Mol Physiol 290(1):153-161. Canniff JP, Batchelor JR, Dodi IA, Harvey W (1985). HLA-typing in oral submucous fibrosis. Tissue Antigens 26(2):138-142. CH H, TY S (1999). immunohistochemical expression of transforming growth factor beta in oral submucous fibrosis. J Acad Formos Stomatol 15(227-239). Chan EC, Jiang F, Peshavariya HM, Dusting GJ (2009). Regulation of cell proliferation by NADPH oxidase-mediated signaling: potential roles in tissue repair, regenerative medicine and tissue engineering. Pharmacol Ther 122(2):97-108. Chang JZ, Yang WH, Deng YT, Chen HM, Kuo MY (2012). EGCG blocks TGFbeta1-induced CCN2 by suppressing JNK and p38 in buccal fibroblasts. Clinical oral investigations. Chang YC, Tai KW, Cheng MH, Chou LS, Chou MY (1998). Cytotoxic and non-genotoxic effects of arecoline on human buccal fibroblasts in vitro. J Oral Pathol Med 27(2):68-71. Chang YC, Tsai CH, Tai KW, Yang SH, Chou MY, Lii CK (2002a). Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 38(5):425-430. Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS (2002b). Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol 38(2):195-200. Cheifetz S (1999). BMP receptors in limb and tooth formation. rit Rev Oral Biol Med 10(2):182-198. Chen A, Zheng S (2008). Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappaB and ERK signalling. Br J Pharmacol 153(3):557-567. Chen HM, Hsieh RP, Yang H, Kuo YS, Kuo MY, Chiang CP (2004). HLA typing in Taiwanese patients with oral submucous fibrosis. J Oral Pathol Med 33(4):191-199. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A (2002). CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int 62(4):1149-1159. Chiang CP, Lang MJ, Liu BY, Wang JT, Leu JS, Hahn LJ et al. (2000a). Expression of p53 protein in oral submucous fibrosis, oral epithelial hyperkeratosis, and oral epithelial dysplasia. J Formos Med Assoc 99(3):229-234. Chiang CP, Lang MJ, Liu BY, Wang JT, Leu JS, Hahn LJ et al. (2000b). Expression of proliferating cell nuclear antigen (PCNA) in oral submucous fibrosis, oral epithelial hyperkeratosis and oral epithelial dysplasia in Taiwan. Oral Oncol 36(4):353-359. Chiang CP, Hsieh RP, Chen TH, Chang YF, Liu BY, Wang JT et al. (2002). High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis. J Oral Pathol Med 31(7):402-409. Dave BJ, Trivedi AH, Adhvaryu SG (1992). Role of areca nut consumption in the cause of oral cancers. A cytogenetic assessment. Cancer 70(5):1017-1023. de Waal J, Olivier A, van Wyk CW, Maritz JS (1997). The fibroblast population in oral submucous fibrosis. J Oral Pathol Med 26(2):69-74. Denton CP, Merkel PA, Furst DE, Khanna D, Emery P, Hsu VM et al. (2007). Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum 56(1):323-333. di Mola FF, Friess H, Martignoni ME, Di Sebastiano P, Zimmermann A, Innocenti P et al. (1999). Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg 230(1):63-71. Djamali A, Vidyasagar A, Adulla M, Hullett D, Reese S (2009). Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant 9(1):74-82. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR (1996). Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. The Journal of investigative dermatology 107(3):404-411. Gaedeke J, Noble NA, Border WA (2004). Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells. Kidney Int 66(1):112-120. Gao R, Brigstock DR (2003). Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res 27(3):214-220. Gao R, Brigstock DR (2004). Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 279(10):8848-8855. Goel A, Kunnumakkara AB, Aggarwal BB (2008). Curcumin as 'Curecumin': from kitchen to clinic. Biochem Pharmacol 75(4):787-809. Grotendorst GR (1997). Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine & growth factor reviews 8(3):171-179. Grotendorst GR, Duncan MR (2005). Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 19(7):729-738. Guha M, Xu ZG, Tung D, Lanting L, Natarajan R (2007). Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. Faseb J 21(12):3355-3368. Haque MF, Harris M, Meghji S, Barrett AW (1998). Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine 10(9):713-719. Haque MF, Meghji S, Khitab U, Harris M (2000). Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med 29(3):123-128. Hardie WD, Le Cras TD, Jiang K, Tichelaar JW, Azhar M, Korfhagen TR (2004). Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 286(4):L741-749. Harvey W, Scutt A, Meghji S, Canniff JP (1986). Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol 31(1):45-49. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC et al. (2009). NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 15(9):1077-1081. Higashiyama H, Yoshimoto D, Kaise T, Matsubara S, Fujiwara M, Kikkawa H et al. (2007). Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis. Exp Mol Pathol 83(1):39-46. Huang SS, Huang JS (2005). TGF-beta control of cell proliferation. J Cell Biochem 96(3):447-462. Igarashi A, Okochi H, Bradham DM, Grotendorst GR (1993). Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4(6):637-645. Ikawa Y, Ng PS, Endo K, Kondo M, Chujo S, Ishida W et al. (2008). Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-beta-induced mouse fibrosis. J Cell Physiol 216(3):680-687. Islam KN, Kayanoki Y, Kaneto H, Suzuki K, Asahi M, Fujii J et al. (1997). TGF-beta1 triggers oxidative modifications and enhances apoptosis in HIT cells through accumulation of reactive oxygen species by suppression of catalase and glutathione peroxidase. Free Radic Biol Med 22(6):1007-1017. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ et al. (1998). Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53(4):853-861. Jacob BJ, Straif K, Thomas G, Ramadas K, Mathew B, Zhang ZF et al. (2004). Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol 40(7):697-704. JD. L (2004). NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4(3):181-189. Jeng JH, Lan WH, Hahn LJ, Hsieh CC, Kuo MY (1996). Inhibition of the migration, attachment, spreading, growth and collagen synthesis of human gingival fibroblasts by arecoline, a major areca alkaloid, in vitro. J Oral Pathol Med 25(7):371-375. Jeng JH, Tsai CL, Hahn LJ, Yang PJ, Kuo YS, Kuo MY (1999). Arecoline cytotoxicity on human oral mucosal fibroblasts related to cellular thiol and esterase activities. Food Chem Toxicol 37(7):751-756. Jeng JH, Chang MC, Hahn LJ (2001). Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 37(6):477-492. Jobling MF, Mott JD, Finnegan MT, Jurukovski V, Erickson AC, Walian PJ et al. (2006). Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. Radiat Res 166(6):839-848. Kantarci A, Black SA, Xydas CE, Murawel P, Uchida Y, Yucekal-Tuncer B et al. (2006). Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis. J Pathol 210(1):59-66. Ko YC, Chiang TA, Chang SJ, Hsieh SF (1992). Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med 21(6):261-264. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC (1995). Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 24(10):450-453. Kumpawat K, Deb S, Ray S, Chatterjee A (2003). Genotoxic effect of raw betel-nut extract in relation to endogenous glutathione levels and its mechanism of action in mammalian cells. Mutat Res 538(1-2):1-12. Kwan HW (1976). A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. Taiwan Yi Xue Hui Za Zhi 75(9):497-505. Larco d, J.E., Todaro GJ (1978). Growth factors from murine sarcoma virus-trnsformed cells. Proc Natl Acad Sci USA 75(8):4001-4005. Leask A, Sa S, Holmes A, Shiwen X, Black CM, Abraham DJ (2001). The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol Pathol 54(3):180-183. Leask A, Abraham DJ (2003). The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 81(6):355-363. Leask A, Holmes A, Black CM, Abraham DJ (2003). Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. The Journal of biological chemistry 278(15):13008-13015. Leask A (2010). Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 106(11):1675-1680. Li G, Xie Q, Shi Y, Li D, Zhang M, Jiang S et al. (2006). Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J Gene Med 8(7):889-900. Lin SC, Lu SY, Lee SY, Lin CY, Chen CH, Chang KW (2005). Areca (betel) nut extract activates mitogen-activated protein kinases and NF-kappaB in oral keratinocytes. Int J Cancer 116(4):526-535. Liu RM, Gaston Pravia KA (2010). Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Radic Biol Med 48(1):1-15. Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW (1994). Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med 23(2):65-69. Mani NJ, Singh B (1976). Studies on Oral Submucous Fibrosis .3. Epithelial Changes. Oral Surg Oral Med O 41(2):203-214. Masamune A, Suzuki N, Kikuta K, Satoh M, Satoh K, Shimosegawa T (2006). Curcumin blocks activation of pancreatic stellate cells. J Cell Biochem 97(5):1080-1093. Massague J (1990). The transforming growth factor-beta family. Annu Rev Cell Biol 6(597-641. Massague J (1998). TGF-beta signal transduction. Annu Rev Biochem 67(753-791. Massague J, Wotton D (2000). Transcription control by the TGF-beta/Smad signaling system. EMBO J 19(8):1745-1754. Mauviel A (1993). Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 53(4):288-295. Meghji S, Scutt A, Harvey W, Canniff JP (1987). An in-vitro comparison of human fibroblasts from normal and oral submucous fibrosis tissue. Arch Oral Biol 32(3):213-215. Meisler N, Keefer KA, Ehrlich HP, Yager DR, Myers-Parrelli J, Cutroneo KR (1997). Dexamethasone abrogates the fibrogenic effect of transforming growth factor-beta in rat granuloma and granulation tissue fibroblasts. J Invest Dermatol 108(3):285-289. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A et al. (1999). Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol 181(1):153-159. Moutasim KA, Jenei V, Sapienza K, Marsh D, Weinreb PH, Violette SM et al.(2010) Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. J Pathol. Moutasim KA, Jenei V, Sapienza K, Marsh D, Weinreb PH, Violette SM et al. (2011). Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. J Pathol 223(3):366-377. Mullen AC, Orlando DA, Newman JJ, Loven J, Kumar RM, Bilodeau S et al. (2011). Master transcription factors determine cell-type-specific responses to TGF-beta signaling. Cell 147(3):565-576. Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Pindborg JJ, Mehta FS (1995). Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing. J Oral Pathol Med 24(4):145-152. Ni WF, Tsai CH, Yang SF, Chang YC (2007). Elevated expression of NF-kappaB in oral submucous fibrosis--evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts. Oral Oncol 43(6):557-562. Oemar BS, Werner A, Garnier JM, Do DD, Godoy N, Nauck M et al. (1997). Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 95(4):831-839. P.J. Sime, Z. Xing, F.L. Graham, K.G. Csaky, Gauldie J (1997). Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100(768-776. Paradis V, Dargere D, Vidaud M, De Gouville AC, Huet S, Martinez V et al. (1999). Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30(4):968-976. Pillai R, Balaram P, Reddiar KS (1992). Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer. Cancer 69(8):2011-2020. Pindborg JJ, Chawla TN, Srivastava AN, Gupta D (1965). Epithelial Changes in Oral Submucous Fibrosis. Acta Odontol Scand 23(277-286. Pindborg JJ, Sirsat SM (1966). Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 22(6):764-779. Pindborg JJ, Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Mehta FS (1984). Oral submucous fibrosis as a precancerous condition. Scand J Dent Res 92(3):224-229. Porter DW, Millecchia LL, Willard P, Robinson VA, Ramsey D, McLaurin J et al. (2006). Nitric oxide and reactive oxygen species production causes progressive damage in rats after cessation of silica inhalation. Toxicological sciences : an official journal of the Society of Toxicology 90(1):188-197. Punithavathi D, Venkatesan N, Babu M (2003). Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. Br J Pharmacol 139(7):1342-1350. Rajalalitha P, Vali S (2005). Molecular pathogenesis of oral submucous fibrosis--a collagen metabolic disorder. J Oral Pathol Med 34(6):321-328. Rajendran R (1994). Oral submucous fibrosis: etiology, pathogenesis, and future research. Bull World Health Organ 72(6):985-996. Rajendran R, Vidyarani (2004). Familial occurrence of oral submucous fibrosis: report of eight families from northern Kerala, south India. Indian J Dent Res 15(4):139-144. Reichart PA, Phillipsen HP (1998). Betel chewer's mucosa--a review. J Oral Pathol Med 27(6):239-242. Reichart PA, CW. VW, D BJ (1994). istribution of procollagen type III, collagen type VI and tenascin in oral submucous fibrosis (OSF). J Oral Pathol Med 23(394-398. RH. M, CC. T, TY S (1995). Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan. J Oral Pathol Med 24(404-412. Scutt A, Meghji S, Canniff JP, Harvey W (1987). Stabilisation of collagen by betel nut polyphenols as a mechanism in oral submucous fibrosis. Experientia 43(4):391-393. Segarini PR, Nesbitt JE, Li D, Hays LG, Yates JR, 3rd, Carmichael DF (2001). The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem 276(44):40659-40667. Sen S, Talukder G, Sharma A (1989). Betel cytotoxicity. J Ethnopharmacol 26(3):217-247. Shah N, Sharma PP (1998). Role of chewing and smoking habits in the etiology of oral submucous fibrosis (OSF): a case-control study. J Oral Pathol Med 27(10):475-479. Shieh DH, Chiang LC, Lee CH, Yang YH, Shieh TY (2004). Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan. J Oral Pathol Med 33(9):581-587. Shieh TY, Yang JF (1992). Collagenase activity in oral submucous fibrosis. Proc Natl Sci Counc Repub China B 16(2):106-110. Sinor PN, Gupta PC, Murti PR, Bhonsle RB, Daftary DK, Mehta FS et al. (1990). A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 19(2):94-98. Sirsat SM, Pindborg JJ (1967). Subepithelial changes in oral submucous fibrosis. Acta Pathol Microbiol Scand 70(2):161-173. Squier CA, Johnson NW (1975). Permeability of oral mucosa. Br Med Bull 31(2):169-175. Srivastava KD, Rom WN, Jagirdar J, Yie TA, Gordon T, Tchou-Wong KM (2002). Crucial role of interleukin-1beta and nitric oxide synthase in silica-induced inflammation and apoptosis in mice. American journal of respiratory and critical care medicine 165(4):527-533. Sundqvist K, Liu Y, Nair J, Bartsch H, Arvidson K, Grafstrom RC (1989). Cytotoxic and genotoxic effects of areca nut-related compounds in cultured human buccal epithelial cells. Cancer Res 49(19):5294-5298. Thangjam GS, Agarwal P, Khan I, Verma UP, Balapure AK, Rao SG et al. (2009). Transglutaminase-2 regulation by arecoline in gingival fibroblasts. J Dent Res 88(2):170-175. Thangjam GS, Kondaiah P (2009). Regulation of oxidative-stress responsive genes by arecoline in human keratinocytes. J Periodontal Res 44(5):673-682. Thannickal VJ, Day RM, Klinz SG, Bastien MC, Larios JM, Fanburg BL et al. (2000). Ras-dependent and independent regulation of reactive oxygen species by mitogenic growth factors and TGF-beta1. Faseb J 14(1741-1748. Thomas SJ, MacLennan R (1992). Slaked lime and betel nut cancer in Papua New Guinea. Lancet 340(8819):577-578. Thompson K, Hamilton DW, Leask A (2010). ALK5 inhibition blocks TGFbeta-induced CCN2 expression in gingival fibroblasts. J Dent Res 89(12):1450-1454. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S (2006). Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42(6):561-568. Trivedy C, Baldwin D, Warnakulasuriya S, Johnson N, Peters T (1997). Copper content in Areca catechu (betel nut) products and oral submucous fibrosis. Lancet 349(9063):1447. Trivedy C, Meghji S, Warnakulasuriya KA, Johnson NW, Harris M (2001). Copper stimulates human oral fibroblasts in vitro: a role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med 30(8):465-470. Tsai CH, Chou MY, Chang YC (2003). The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med 32(3):146-153. Tsai CH, Yang SF, Chen YJ, Chu SC, Hsieh YS, Chang YC (2004). Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels. Oral Dis 10(6):360-364. Tsai CH, Yang SF, Chen YJ, Chou MY, Chang YC (2005a). The upregulation of insulin-like growth factor-1 in oral submucous fibrosis. Oral Oncol 41(9):940-946. Tsai CH, Yang SF, Chen YJ, Chou MY, Chang YC (2005b). Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro. J Oral Pathol Med 34(2):100-105. Tsai CH, Yang SF, Chang YC (2007). The upregulation of cystatin C in oral submucous fibrosis. Oral Oncol 43(7):680-685. Tsai CH, Yang SF, Lee SS, Chang YC (2009). Augmented heme oxygenase-1 expression in areca quid chewing-associated oral submucous fibrosis. Oral Dis 15(4):281-286. Vicencio AG, Lee CG, Cho SJ, Eickelberg O, Chuu Y, Haddad GG et al. (2004). Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia? Am J Respir Cell Mol Biol 31(6):650-656. Wang H, Kochevar IE (2005). Involvement of UVB-induced reactive oxygen species in TGF-beta biosynthesis and activation in keratinocytes. Free Radic Biol Med 38(7):890-897. Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC (2003). The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 39(4):367-372. Yang SF, Hsieh YS, Tsai CH, Chen YJ, Chang YC (2007). Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis. Oral Dis 13(2):234-238. Yang SF, Tsai CH, Chang YC (2008). The upregulation of heat shock protein 47 expression in human buccal fibroblasts stimulated with arecoline. J Oral Pathol Med 37(4):206-210. Yang YH, Lee HY, Tung S, Shieh TY (2001). Epidemiological survey of oral submucous fibrosis and leukoplakia in aborigines of Taiwan. J Oral Pathol Med 30(4):213-219. Yang YH, Chen CH, Chang JS, Lin CC, Cheng TC, Shieh TY (2005). Incidence rates of oral cancer and oral pre-cancerous lesions in a 6-year follow-up study of a Taiwanese aboriginal community. J Oral Pathol Med 34(10):596-601. Yu CC, Hsu MJ, Kuo ML, Chen RF, Chen MC, Bai KJ et al. (2009). Thrombin-induced connective tissue growth factor expression in human lung fibroblasts requires the ASK1/JNK/AP-1 pathway. Journal of immunology 182(12):7916-7927. Yusuf H, Yong SL (2002). Oral submucous fibrosis in a 12-year-old Bangladeshi boy: a case report and review of literature. Int J Paediatr Dent 12(4):271-276. Zheng S, Chen A (2004). Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro. Biochem J 384(Pt 1):149-157. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/16143 | - |
dc.description.abstract | 結締組織生長因子(CTGF/CCN2) 在許多人類器官組織的纖維化病變中扮演了重要角色。口腔黏膜下纖維化症 (OSF)是一種不可逆的口腔黏膜纖維性病變。流行病學研究指出,嚼檳榔是口腔黏膜下纖維化症的最主要致病因子。本研究首先利用免疫組織化學染色方法,探討CCN2於20例OSF及10例正常口腔黏膜(NOM)中的表現。 結果發現在所有的 OSF 檢體中都有 CCN2的陽性染色,主要表現於纖維母細胞及內皮細胞,NOM 則幾乎沒有表現。以檳榔鹼 arecoline 刺激人類頰黏膜纖維母細胞(BMFs),可以誘導BMFs 中CCN2表現。Arecoline 刺激CCN2過度表現可能是嚼食檳榔誘導OSF發生的機轉之一。前處理 NF-κB專一性抑制劑Bay 117082、JNK專一性抑制劑 SP600125、p38 MAPK專一性抑制劑SB203580、抗氧化劑N-acetylcysteine (NAC) 都可以明顯的減少BMF中arecoline誘導CCN2的表現。因此Arecoline可能透過活性氧分子群 ( Reactive oxygen species,ROS),NF-kB,JNK及p38 MAPK 路徑誘導BMFs中CCN2的表現。薑黃素(curcumin)可以幾乎完全阻斷BMF中arecoline誘導的CCN2表現。此外TGF-β 中和抗體1D11、TβRI/ALK5的專一性抑制劑SB431542、Smad3的專一性抑制劑SIS3也可以抑制BMF中arecoline誘導的CCN2 表現。Arecoline可以誘導BMF中Smad2 和 Smad3 的磷酸化。可見得arecoline是經由TGF-β訊息傳導路徑誘導BMF的CCN2表現。此外NADPH氧化酶(NOX)的活化及活性氧物種被認為和許多人類器官組織的纖維化病變有關。我們利用泛NOX抑制劑diphenyleneiodonium chloride (DPI)、NOX4抑制劑plumbagin 及NAC前處理細胞可抑制BMF中arecoline誘導的CCN2 表現,但NOX2抑制劑 apocynin及muscarinic接受器拮抗劑 atropine 則沒有影響。可見得NOX4亦參與arecoline誘導BMF的CCN2訊息傳導路徑。本研究結果提供嚼食檳榔誘導OSF發生的新機轉及其調控方式。冀望未來可以藉由抑制CCN2來達到抑制或治療口腔黏膜下纖維化症。 | zh_TW |
dc.description.abstract | Connective tissue growth factor (CCN2) is associated with the onset and progression of fibrosis in many human tissues. Areca nut (AN) chewing is the most important etiological factor in the pathogenesos of oral submucous fibrosis (OSF). We first immunohistochemically examined the expression of CCN2 protein in 20 cases of OSF and found positive CCN2 staining in fibroblasts and endothelial cells in all cases. Western blot analysis showed the arecoline, a main alkaloid found in AN, stimulated CCN2 synthesis in a dose- and time- dependent manner in buccal mucosal fibroblasts. Constitutive overexpression of CCN2 during AN chewing may enhance the fibrotic activity in OSF and play a role in the pathogenesis of OSF. Pretreatment with NF-κB inhibitor Bay 11-7082、JNK inhibitor SP600125、p38 MAPK inhibitor SB203580、antioxidatn N-acetyl-L-cycteine, but not ERK inhibitor PD98059, significantly reduced arecoline-induced CCN2 synthesis. Curcumin completely inhibited arecolined-induced CCN2 synthesis and the inhibition is dose-dependent. Arecoline also induced Smad 2 and Smad 3 activation. TGF-β neutralizing antibody、activin receptor-like kinase 5 (ALK5) inhibitor SB431542、Smad 3 inhibitor SIS3 significantly reduced arecoline-induced CCN2 synthesis. Furthermore, arecolined-induced CCN2 synthesis was inhibited by diphenyleneiodonium (DPI), a NADPH oxidase (NOX) inhibitor, NOX4 inhibitor plumbagin, but not muscarinic receptor antagonist atropine and NOX2 inhibitor apocynin. These results indicate that arecoline induced CCN2 expression in buccal mucosal fibroblasts via TGF-β signaling pathway. Curcumin may serve as a useful agent in controlling OSF. | en |
dc.description.provenance | Made available in DSpace on 2021-06-07T18:02:40Z (GMT). No. of bitstreams: 1 ntu-101-Q95422002-1.pdf: 3068151 bytes, checksum: 34c6b3f963bacc093bcbb256f510da86 (MD5) Previous issue date: 2012 | en |
dc.description.tableofcontents | 誌謝......................................................I
中文摘要.................................................III ABSTRACT..................................................IV 目錄.......................................................V 圖目錄...................................................VII 導論.......................................................1 第一節 口腔黏膜下纖維化症 ( ORAL SUBMUCOUS FIBROSIS )......1 1-1 口腔黏膜下纖維化症的臨床症狀..........................1 1-2 口腔黏膜下纖維化症的組織病理學........................1 1-3 口腔黏膜下纖維化症的流行病學..........................2 1-4 口腔黏膜下纖維化症的致病機轉..........................3 1-5 口腔黏膜下纖維化症的治療..............................3 第二節 嚼檳榔與口腔黏膜下纖維化症..........................4 第三節 轉化生長因子β (TRANSFORMING GROWTH FACTOR -β )....5 3-1 TGF-β................................................5 3-2 TGF-β1的活化與訊息傳遞路徑...........................6 3-3 TGF-β1與纖維化.......................................8 第四節 結締組織生長因子( CONNECTIVE TISSUE GROWTH FACTOR/ CCN2 )....................................................10 4-1 CCN2.................................................10 4-2 CCN2的訊息調控.......................................11 4-3 CCN2與纖維化.........................................11 第五節 活性氧物種 (REACTIVE OXYGEN SPECIES)...............12 5-1 Reactive oxygen species..............................12 5-2 ROS與纖維化..........................................12 5-3 ROS會活化TGF-β並促進TGF-β基因表現..................13 5-4 NADPH Oxidase (NOX)..................................14 第六節 薑黃素 (CRUCUMIN)..................................15 實驗目的..................................................16 實驗材料與方法............................................17 第一節 免疫組織染色法 ( IMMUNOHISTOCHEMISTRY STAINING )...17 第二節 細胞株與細胞培養 ( CELL CULTURE )..................19 第三節 藥物處理 ( MATERIALS ).............................20 第四節 西方墨點法( WESTERN BLOT)..........................21 第五節 基因分析表現 ......................................24 第六節 以流式細胞儀測定細胞反應性氧化物種.................26 第七節 數據標準化與統計分析...............................26 結果......................................................27 討論......................................................32 圖........................................................39 參考文獻..................................................53 附錄I.....................................................67 | |
dc.language.iso | zh-TW | |
dc.title | 檳榔鹼Arecoline經由TGF-β訊息傳遞路徑誘導人類頰黏膜纖維母細胞結締組織生長因子表現之研究 | zh_TW |
dc.title | Arecoline-induced CCN2 expression in human buccal mucosal fibroblasts via TGF-β signaling pathway | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 張國威,張育超,周涵怡,郭生興 | |
dc.subject.keyword | 口腔黏膜下纖維化症,檳榔鹼,結締組織生長因子,轉化生長因子β,薑黃素, | zh_TW |
dc.subject.keyword | Arecoline,CCN2,Curcumin,Oral submucous fibrosis,TGF-β, | en |
dc.relation.page | 73 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2012-08-03 | |
dc.contributor.author-college | 牙醫專業學院 | zh_TW |
dc.contributor.author-dept | 臨床牙醫學研究所 | zh_TW |
顯示於系所單位: | 臨床牙醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-101-1.pdf 目前未授權公開取用 | 3 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。